Shanghai MicroPort Endovascular MedTech Group Co Ltd
SSE:688016
Relative Value
The Relative Value of one
Shanghai MicroPort Endovascular MedTech Group Co Ltd
stock under the Base Case scenario is
89.35
CNY.
Compared to the current market price of 96.95 CNY,
Shanghai MicroPort Endovascular MedTech Group Co Ltd
is
Overvalued by 8%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
Shanghai MicroPort Endovascular MedTech Group Co Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Shanghai MicroPort Endovascular MedTech Group Co Ltd
SSE:688016
|
12B CNY | 9.5 | 31.6 | 20.1 | 20.1 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
62.5B USD | 0 | 0 | 0 | 0 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.3T JPY | 10.2 | 37.2 | 26.5 | 31.9 | |
| CH |
|
Alcon AG
SIX:ALC
|
31.8B CHF | 4.1 | 39.6 | 16.3 | 31.7 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
108.5B DKK | 3.9 | 27.2 | 14.2 | 16.9 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.7B USD | 3.4 | 33.3 | 17.7 | 23 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.7B GBP | 2.8 | 30.2 | 13.3 | 21.7 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
6.3B USD | 1.2 | -17.6 | 18.1 | 58.5 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
40.9B CNY | 9 | 24.8 | 22.3 | 22.3 | |
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
4.1B CHF | 5.2 | 21.1 | 13.7 | 18.6 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
790.8B JPY | 6.1 | 44.7 | 21 | 28.5 |